Reid TR - Search Results

1

Epothilones: a novel class of microtubule-stabilizing drugs for the treatment of cancer.

Trivedi M, Budihardjo I, Loureiro K, Reid TR, Ma JD. Trivedi M, et al. Among authors: reid tr. Future Oncol. 2008 Aug;4(4):483-500. doi: 10.2217/14796694.4.4.483. Future Oncol. 2008. PMID: 18684060 Review.

2

Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin.

Reid TR, Freeman S, Post L, McCormick F, Sze DY. Reid TR, et al. Cancer Gene Ther. 2005 Aug;12(8):673-81. doi: 10.1038/sj.cgt.7700819. Cancer Gene Ther. 2005. PMID: 15803147 Clinical Trial.

3

Virus combinations and chemotherapy for the treatment of human cancers.

Kumar S, Gao L, Yeagy B, Reid T. Kumar S, et al. Curr Opin Mol Ther. 2008 Aug;10(4):371-9. Curr Opin Mol Ther. 2008. PMID: 18683102 Review.

4

Navigating the clinical development landscape for oncolytic viruses and other cancer therapeutics: no shortcuts on the road to approval.

Breitbach CJ, Reid T, Burke J, Bell JC, Kirn DH. Breitbach CJ, et al. Cytokine Growth Factor Rev. 2010 Apr-Jun;21(2-3):85-9. doi: 10.1016/j.cytogfr.2010.02.001. Epub 2010 May 15. Cytokine Growth Factor Rev. 2010. PMID: 20472490 Review.

5

Rewriting the epigenetic code for tumor resensitization: a review.

Oronsky B, Oronsky N, Scicinski J, Fanger G, Lybeck M, Reid T. Oronsky B, et al. Transl Oncol. 2014 Oct 24;7(5):626-31. doi: 10.1016/j.tranon.2014.08.003. eCollection 2014 Oct. Transl Oncol. 2014. PMID: 25389457 Free PMC article. Review.

6

The war on cancer: a military perspective.

Oronsky B, Carter CA, Mackie V, Scicinski J, Oronsky A, Oronsky N, Caroen S, Parker C, Lybeck M, Reid T. Oronsky B, et al. Front Oncol. 2015 Jan 26;4:387. doi: 10.3389/fonc.2014.00387. eCollection 2014. Front Oncol. 2015. PMID: 25674537 Free PMC article. Review.

7

Phase I study of everolimus, cetuximab and irinotecan as second-line therapy in metastatic colorectal cancer.

Hecht JR, Reid TR, Garrett CR, Beck JT, Davidson SJ, Mackenzie MJ, Brandt U, Rizvi S, Sharma S. Hecht JR, et al. Among authors: reid tr. Anticancer Res. 2015 Mar;35(3):1567-73. Anticancer Res. 2015. PMID: 25750312 Clinical Trial.

8

Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study.

Reid T, Oronsky B, Scicinski J, Scribner CL, Knox SJ, Ning S, Peehl DM, Korn R, Stirn M, Carter CA, Oronsky A, Taylor MJ, Fitch WL, Cabrales P, Kim MM, Burris HA Rd, Lao CD, Abrouk NED, Fanger GR, Infante JR. Reid T, et al. Lancet Oncol. 2015 Sep;16(9):1133-1142. doi: 10.1016/S1470-2045(15)00089-3. Epub 2015 Aug 19. Lancet Oncol. 2015. PMID: 26296952 Clinical Trial.

9

Confirmatory Trials in the Evaluation of Anticancer Medicinal Products in Man--PFS2: A Measure of Therapeutic Action-At-A-Distance.

Oronsky B, Carter CA, Reid TR, Scicinski J, Oronsky A, Lybeck M, Caroen S, Stirn M, Oronsky N, Langecker P. Oronsky B, et al. Among authors: reid tr. Neoplasia. 2015 Sep;17(9):716-722. doi: 10.1016/j.neo.2015.09.001. Neoplasia. 2015. PMID: 26476079 Free PMC article. Review.

10

"No patient left behind": an alternative to "the War on Cancer" metaphor.

Oronsky BT, Carter CA, Oronsky AL, Salacz ME, Reid T. Oronsky BT, et al. Med Oncol. 2016 Jun;33(6):55. doi: 10.1007/s12032-016-0769-1. Epub 2016 Apr 29. Med Oncol. 2016. PMID: 27129923

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results